PNPLA3 and metabolic dysfunction-associated steatotic liver disease: From a clinical point of view, our data confirm that NAFLD patients are at high risk of carotid atherosclerosis, especially in the presence of classical risk factors, in younger patients with PNPLA3 GG genotype, and in patients aged 50 or more.